LIF and OM Directly Interact with a Soluble Form of gp130, the IL-6 Receptor Signal Transducing Subunit

References

• Aruffo A., Dietsch, Wan M. T. H., Hellstrom K. E., Hellstrom I. Granule membrane protein 140 (GM140) binds to carcinomas and carcinoma-derived cell lines. Proc. Natl Acad. Sci. USA 1992; 89: 2292–2296
   PubMed Web of Science ®Google Scholar
• Baumann H., Wong G. G. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia inhibitory factor. J. Immunol 1989; 143: 1163–1167
   PubMed Web of Science ®Google Scholar
• Bazan J. Proc. Natl Acad. Sci. USA 1990; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Bazan J. Neuropoietic cytokines in the hematopoietic fold. Neuron 1991; 7: 197–208
   PubMed Web of Science ®Google Scholar
• Bruce A G., Linsley P. S., Rose T. M. Prog. Growth Factor Res 1993; 4: 157–170
   Google Scholar
• Davis S., Aldrich T. H., Stahl N., Pan I., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFRB and gp130 as Heterodimerizing Signal Transducers of the Tripartite CNTF receptor. Science 1993; 260: 1805–1808
   PubMed Web of Science ®Google Scholar
• Davis S., Aldrich T. H., Valenzuela D. M., Wong V., Furth M. E., Squinto S. P., Yancopoulos G. D. The receptor for ciliary neurotrophic factor. Science 1991; 253: 59–63
   PubMed Web of Science ®Google Scholar
• Fukunaga R., Ishizaka-Ikeda E., Pan C. X., Seto Y., Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 1991; 10: 2855–2865
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Bruce A. G. Oncostatin M binds the high-affinity leukemia inhibitory factor. New Biol 1992; 4: 61–65
   PubMedGoogle Scholar
• Gearing D. P., Comeau M. R., Freind D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B., Ziegler S. F., Cosman D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434–1437
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Thut C. J., VandenBos T., Gimpel S. D., Delany P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to IL-6 signal reansducer, gp130. EMBO J 1991; 10: 2839–2848
   PubMed Web of Science ®Google Scholar
• Godard A, Heymann D., Raher S., Anegon I., Peyrat M.-A., Le-Mauf B., Mouray E., Gregoire M., Virdee K., Soulillou J.-P., Moreau J.-F., Jaques Y. High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells: molecular characterization and cellular distribution. J. Biol. Chem 1992; 267: 3214–3222
   PubMed Web of Science ®Google Scholar
• Grove R., Mazzucco C. E., Radka S. F., Shoyab M., Kiener P. A. Oncostatin M upregulates LDL receptor in HepG2 cells by a novel mechanism. J. Biol. Chem 1991; 266: 18194–18199
   PubMed Web of Science ®Google Scholar
• Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149–1157
   PubMed Web of Science ®Google Scholar
• Ip N. Y., Nye S. H., Boulton T. G., Davis S. D., Taga T., Li Y., Birren S. J., Yasukawa K., Kishimoto T., Anderson D. J., Stahl N., Yancopoulos G. D. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121–1132
   PubMed Web of Science ®Google Scholar
• Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y.-F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human human cell line that proliferates dependently on GMCSF, IL-3 or Erythropoietin. J. Cell. Physiol 1989; 140: 323–334
   PubMed Web of Science ®Google Scholar
• Leary A. G., Wong G. G., Clark S. C., Smith A. G., Ogawa M. Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. Blood 1990; 75: 1960–1964
   PubMed Web of Science ®Google Scholar
• Linsley P. S., Bolton-Hanson M., Horn D., Malik N., Kallestad J. C., Ochs V., Zarling J., Shoyab M. Identification and characterization of cellular receptor for the growth regulator, oncostatin M. J. Biol. Chem 1989; 264: 4282–4289
   PubMed Web of Science ®Google Scholar
• Liu J., Modrell B., Aruffo A., Marken J. S., Taga T., Yasukawa K., Murakami M., Kishimoto T., Shoyab M. Interleukin-6 signal transducer, gp130 mediates oncostatin M signal. J. Biol. Chem 1992; 267: 16763–16766
   PubMed Web of Science ®Google Scholar
• Liu J., Modrell B., Aruffo A., Scharnowske S., Shoyab M. Interactions between oncostatin M and the IL-6 signal transducer, gp130. Cytokine 1994; 6: 272–278
   PubMed Web of Science ®Google Scholar
• Maekawa T., Metcalf D. Clonal suppression of HL60 and U937 cells by recombinant human leukemia inhibitory factor in combination with GM-CSF or G-CSF. Leukemia 1989; 3: 270–276
   PubMed Web of Science ®Google Scholar
• Malik N., Graves D., Shoyab M., Purchio A. F. Amplification and expression of heterologous oncostatin M in chinese hamster overy cells. DNA and Cell Biol 1992; 11: 453–459
   PubMed Web of Science ®Google Scholar
• Mori M., Yamaguchi K., Abe K. Purification of a lipoprotein lipase-inhibitory protein produced by a melanoma cell line associated with cancer cachexia. Biochem. Biophys. Res. Commun 1989; 160: 1085–1092
   PubMed Web of Science ®Google Scholar
• Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6 induced homodimerization of gp130 and Associated Activation of a Tyrosine Kinase. Science 1993; 260: 1808–1810
   PubMed Web of Science ®Google Scholar
• Narazaki M., Yasukawa K., Saito T., Ohsugi Y., Fukui H., Koishihara Y., Yancopoulos G. D., Taga T., Kishimoto T. Soluble forms of the Interleukin-6 Signal-Transducing Receptor Component gp130 in Human Serum Possessing a Potential to Inhibit Signals Through Membrane-Anchored gp130. Blood 1993; 82: 1120–1126
   PubMed Web of Science ®Google Scholar
• Rao M. S., Symes A., Malik N., Shoyab M., Fink J. S., Landis S. C. Oncostatin M regulates VIP expression in a human neuroblastoma cell line. Neuro Report 1992; 3: 865–868
   PubMed Web of Science ®Google Scholar
• Richards C. D., Brown T. J., Shoyab M., Baumann H., Gauldie J. Recombinant oncostatin M stimulates the production of acute phase protein in HepG2 cells and rat primary hepatocyte. in vitro. J. Immunol 1992; 148: 1731–1736
   PubMed Web of Science ®Google Scholar
• Richards C. D., Shoyab M., Brown T. J., Gauldie J. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J. Immunol 1993; 150: 5596–5603
   PubMed Web of Science ®Google Scholar
• Rose T. M., Bruce A. G. Oncostatin M is a member of cytokine family that includes leukemia inhibitory factor, granulocyte colony stimulating factor, and interleukin 6. Proc. Natl Acad. Sci. USA 1991; 88: 8641–8645
   PubMed Web of Science ®Google Scholar
• Saito M., Yoshida K., Hibi M., Taga T., Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J. Immunol 1992; 148: 4066–4071
   PubMed Web of Science ®Google Scholar
• Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin 6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573–581
   PubMed Web of Science ®Google Scholar
• Taga T., Kishimoto T. Cytokine receptors and signal transduction. FASEB 1992; 6: 3387–3396
   PubMed Web of Science ®Google Scholar
• Taga T., Narazaki M., Yasukawa K., Saito T., Miki D., Hamaguchi M., Davis S., Shoyab M., Yancopolous G. D., Kishimoto T. Functional inhibition of hematopoietic and neurottrophic cytokines (LIF, OM, and CNTF) by blocking IL-6 signal transducer, gp130. Proc. Natl Acad. Sci. USA 1992; 89: 10998–11001
   PubMed Web of Science ®Google Scholar
• Waring P., Wycherley K., Cary D., Nicola N., Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J. Clin. Invest 1992; 90: 2031–2037
   PubMed Web of Science ®Google Scholar
• Williams R. L., Hilton D. J., Pease S., Wilson T. A., Stewart C A., Gearing D. P., Wagner E. F., Metcalf D., Nicola N. A., Gough N. M. Myeloid leukemia inhibitory factor maintains the development potential of embryonic stem cells. Nature 1988; 336: 684–687
   PubMed Web of Science ®Google Scholar
• Yamamori T., Sarai A. Coevolution of cytokine receptor families in the immune and neruous systems. Neurosci. Res 1992; 15: 151–161
   PubMed Web of Science ®Google Scholar
• Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto H. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988; 241: 825–828
   PubMed Web of Science ®Google Scholar
• Zarling J. M., Shoyab M., Marquardt, Bolton-Hanson M., Lioubin M. N., Todaro G. J. Oncostatin M is a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl Acad. Sci. USA 1986; 83: 9739–9743
   PubMed Web of Science ®Google Scholar